vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and FULTON FINANCIAL CORP (FULT). Click either name above to swap in a different company.
FULTON FINANCIAL CORP is the larger business by last-quarter revenue ($336.2M vs $236.8M, roughly 1.4× CROSS COUNTRY HEALTHCARE INC). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs -35.0%, a 63.2% gap on every dollar of revenue. On growth, FULTON FINANCIAL CORP posted the faster year-over-year revenue change (4.2% vs -23.6%). Over the past eight quarters, FULTON FINANCIAL CORP's revenue compounded faster (0.2% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
CCRN vs FULT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $336.2M |
| Net Profit | $-82.9M | $94.8M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | — |
| Net Margin | -35.0% | 28.2% |
| Revenue YoY | -23.6% | 4.2% |
| Net Profit YoY | -2109.7% | 1.9% |
| EPS (diluted) | $-2.56 | $0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.2M | ||
| Q4 25 | $236.8M | $336.0M | ||
| Q3 25 | $250.1M | $334.6M | ||
| Q2 25 | $274.1M | $324.1M | ||
| Q1 25 | $293.4M | $318.4M | ||
| Q4 24 | $309.9M | $319.6M | ||
| Q3 24 | $315.1M | $317.7M | ||
| Q2 24 | $339.8M | $334.7M |
| Q1 26 | — | $94.8M | ||
| Q4 25 | $-82.9M | $99.0M | ||
| Q3 25 | $-4.8M | $100.5M | ||
| Q2 25 | $-6.7M | $99.2M | ||
| Q1 25 | $-490.0K | $93.0M | ||
| Q4 24 | $-3.8M | $68.6M | ||
| Q3 24 | $2.6M | $63.2M | ||
| Q2 24 | $-16.1M | $95.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | -30.2% | 35.7% | ||
| Q3 25 | -2.4% | 38.2% | ||
| Q2 25 | -2.1% | 37.8% | ||
| Q1 25 | -0.3% | 36.1% | ||
| Q4 24 | -1.1% | 27.0% | ||
| Q3 24 | 0.9% | 25.1% | ||
| Q2 24 | -5.7% | 30.8% |
| Q1 26 | — | 28.2% | ||
| Q4 25 | -35.0% | 29.5% | ||
| Q3 25 | -1.9% | 30.0% | ||
| Q2 25 | -2.4% | 30.6% | ||
| Q1 25 | -0.2% | 29.2% | ||
| Q4 24 | -1.2% | 21.5% | ||
| Q3 24 | 0.8% | 19.9% | ||
| Q2 24 | -4.7% | 28.4% |
| Q1 26 | — | $0.55 | ||
| Q4 25 | $-2.56 | $0.53 | ||
| Q3 25 | $-0.15 | $0.53 | ||
| Q2 25 | $-0.20 | $0.53 | ||
| Q1 25 | $-0.02 | $0.49 | ||
| Q4 24 | $-0.13 | $0.36 | ||
| Q3 24 | $0.08 | $0.33 | ||
| Q2 24 | $-0.47 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $3.5B |
| Total Assets | $449.0M | $32.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | — | ||
| Q2 25 | $81.2M | — | ||
| Q1 25 | $80.7M | — | ||
| Q4 24 | $81.6M | — | ||
| Q3 24 | $64.0M | — | ||
| Q2 24 | $69.6M | — |
| Q1 26 | — | $3.5B | ||
| Q4 25 | $322.8M | $3.5B | ||
| Q3 25 | $408.1M | $3.4B | ||
| Q2 25 | $412.2M | $3.3B | ||
| Q1 25 | $418.2M | $3.3B | ||
| Q4 24 | $419.0M | $3.2B | ||
| Q3 24 | $424.7M | $3.2B | ||
| Q2 24 | $433.3M | $3.1B |
| Q1 26 | — | $32.2B | ||
| Q4 25 | $449.0M | $32.1B | ||
| Q3 25 | $538.2M | $32.0B | ||
| Q2 25 | $553.8M | $32.0B | ||
| Q1 25 | $576.2M | $32.1B | ||
| Q4 24 | $589.3M | $32.1B | ||
| Q3 24 | $597.4M | $32.2B | ||
| Q2 24 | $602.9M | $31.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $304.5M | ||
| Q3 25 | $20.1M | $116.1M | ||
| Q2 25 | $4.2M | $91.7M | ||
| Q1 25 | $5.7M | $703.0K | ||
| Q4 24 | $24.2M | $416.6M | ||
| Q3 24 | $7.5M | $-22.0M | ||
| Q2 24 | $82.4M | $157.8M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.08× | ||
| Q3 25 | — | 1.16× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 6.07× | ||
| Q3 24 | 2.92× | -0.35× | ||
| Q2 24 | — | 1.66× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
FULT
Segment breakdown not available.
